In this special report on AI in healthcare, CNN BA sat down with our Deputy CEO, Naser Al Yammahi, in addition to hashtag HayatBiotech’s Senior Medical Advisor, Dr. Nawal Al Kaabi, to get an in-depth perspective on the practical applications of using artificial intelligence when conducting clinical trials.
Among a multitude of advantages, the report touches on how AI has immense potential to drive enhanced volunteer engagement in clinical trials, paving the way for a more decentralised approach in the pursuit of innovative healthcare solutions. Moreover, Dr. Al Kaabi sheds light on how AI has the capability to analyse data in real time and its role in supporting researchers in rapid trend identification and improved decision-making processes.
Based on his extensive involvement in private-public collaborations and clinical trial management, Naser Al Yammahi also provides his view on the value of adopting a collaborative mindset, the importance of upholding ethical practices, and the challenges facing the Life Sciences industry while integrating AI to yield enhanced results.
We invite you to delve into more details on the boundless potential of AI, by clicking on the link below.
Watch the full report here: The role of artificial intelligence is increasing in the medical sector and changing the features of clinical trials – CNN Economic